Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-11

FDA Approved: ARIPIPRAZOLE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Bionpharma's ARIPIPRAZOLE as an original application generic, allowing marketing for the same indications as the reference product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

ORIG AP for ARIPIPRAZOLE (ARIPIPRAZOLE)